Anti-HAVCR2 Neutralizing Antibody (V3S-0522-YC2244) (CAT#: V3S-0522-YC2244)

Send Inquiry
  • fig1
    Figure 1 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in SDS-PAGE
  • fig1
    Figure 2 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in WB
  • fig1
    Figure 3 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in SEC-HPLC
  • fig1
    Figure 4 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in WB
  • fig1
    Figure 5 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in ELISA

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Hepatitis A virus cellular receptor 2. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation.
Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free.
Clonality Monoclonal
Host Species Human
Target Species Human
Affinity KD = 23 nM, determined by surface plasmon resonance.
Isotype lgG1

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and/or SEC-HPLC
Endotoxin <1 EU/mg, determined by LAL method
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C.

Applications

Application ELISA; WB; Block; FuncS
Application Notes The antibody is recommended for detection of HAVCR2 by Block, FuncS assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target HAVCR2
Alternative Name Hepatitis A Virus Cellular Receptor 2; T-Cell Immunoglobulin And Mucin Domain-Containing Protein 3; T-Cell Immunoglobulin Mucin Family Member 3; T-Cell Immunoglobulin Mucin Receptor 3; T-Cell Membrane Protein 3; HAVcr-2; TIMD-3; Tim-3;
Gene ID 84868
UniProt Q8TDQ0
Research Area Immunology

Tested Data

SDS-PAGE

Figure 1 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in SDS-PAGE

SDS-PAGE analysis of V3S-0522-YC2244 in non-reduced (lane 1) and β-mercaptoethanol-reduced (lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively. And non-reduced protein migrates as 200 kDa.

Figure 1 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in SDS-PAGE

WB

Figure 2 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in WB

Western blot analysis of V3S-0522-YC2244 was performed by loading 2 µg onto a 12% Tris-HCl polyacrylamide gel in non-reduced (lane 1) and β-mercaptoethanol-reduced (lane 2) conditions. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with Goat Anti-Human IgG HRP secondary antibody at a dilution of 1:8,000 for 75 minutes. Chemiluminescent detection was performed.

Figure 2 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in WB

HPLC

Figure 3 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in SEC-HPLC

The purity of V3S-0522-YC2244 was greater than 95% as determined by SEC-HPLC.

Column: 3 µm, 7.8 x 300 nm
Mobile phase: 150 mM Sodium Phosphate Buffer, pH 7.3
Detection: UV 280 nm
Injection: 25 µl

Figure 3 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in SEC-HPLC

WB

Figure 4 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in WB

Western blot analysis was performed by loading 5 µg (lane 1) and 2 µg (lane 2) recombinant human HAVCR2 Protein onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least 1 hour. Membranes were probed with Anti-HAVCR2 Antibody (V3S-0522-YC2244) at a dilution of 1:1000 overnight at 4°C on a rocking platform. Then probed with Goat anti-Human IgG HRP secondary antibody at a dilution of 1:8,000 for one hour. Chemiluminescent was detected.

Figure 4 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in WB

ELISA

Figure 5 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in ELISA

ELISA analysis of V3S-0522-YC2244 was performed by coating with recombinant human HAVCR2 Protein. Then blocked with BSA, and incubated with Anti-HAVCR2 Antibody (V3S-0522-YC2244) at a starting concentration of 2.5 µg/mL. The HRP-conjugated goat anti-human IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.

Figure 5 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in ELISA

For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
Online Inquiry